Abbott Laboratories initiated with "outperform"

11/12/09 - Wedbush Morgan Securities

NEW YORK, November 12 (newratings.com) - Analysts at Wedbush Morgan initiate coverage of Abbott Laboratories (ABT) with an "outperform" rating. The target price is set to $62.